CYTK FY 2012 Earnings — Cytokinetics, Incorporated Revenue & Financial Results | Market Cap Arena

CYTKCytokinetics, Incorporated

$8B

FY 2012 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$8M+89.0% YoY

Gross Profit

-$28M-371.5% margin

Operating Income

-$39M-517.3% margin

Net Income

-$42M-551.4% margin

EPS (Diluted)

$-2.15

Cash Flow

Operating Cash Flow

-$33M

Free Cash Flow

-$34M

Stock-Based Comp.

$4M

Balance Sheet

Total Assets

$78M

Total Liabilities

$6M

Stockholders' Equity

$71M

Cash & Equivalents

$15M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$8M	$4M	+89.0%
Gross Profit	-$28M	$4M	-802.1%
Operating Income	-$39M	-$48M	+18.5%
Net Income	-$42M	-$48M	+12.9%